Case Report Created By : BUNGA LISTIA PARAMITA (110.2006.059) RIA RIZKY DESLISYAHPUTRI (110.2006.221) RESI TRISMAYENNY (0718011078) Perceptor: Dr. DEDY ZAIRUS, Sp.P 1
Case Report
Created By :BUNGA LISTIA PARAMITA (110.2006.059)
RIA RIZKY DESLISYAHPUTRI (110.2006.221)RESI TRISMAYENNY (0718011078)
Perceptor:Dr. DEDY ZAIRUS, Sp.P
CLINICAL WORK OF INTERNAL MEDICINE, SMF. PULMONOLOGY
PERIOD 26TH MARCH – 26TH MAY 2012ABDUL MOELOEK HOSPITAL, BANDAR LAMPUNG
1
THE UNIT PULMONOLOGY OF INTERNAL MEDICINE …………………………………………….……
RSUD Dr. Hi. ABDUL MOELOEK…………………………………………….……
BANDARLAMPUNG
PATIENT STATUS
PATIENT IDENTITY
Full Name : NurimanSex : maleAge : 35 years oldNationality : JavaneseMarital status : MarriedReligion : IslamOccupation : Farmer Educational background : Senior High schoolAddress : Rantau Tijang Tanggamus
ANAMNESIS
Taken From : Autoanamnesis Date 12nd April 2012 11.30 WIB
The main complained : Dyspneu
The additional complained : Chest pain, Febris, Purulent cough, Night sweat.
The History of the Illness :
Patients come to RSUDAM with complaints of shortness of breath since 2 months
ago and felt become heavy since one week before entering RSUDAM. Perceived shortness
of breath and intermittent positions are not affected by weather and activity. Patients also
complained of intermittent cough since one year ago. Cough accompanied by a discharge
of pus, in which pus is reduced when the patient entered the hospital. Other than that the
patient also complained of chest pain that arises after the cough. Cough is more severe if
the patient is seated. Patients also felat that he had water on the right chest move the
patient to move position. In addition, patients also complain of fever, sepecially late
afternoon and night sweat. The patient claimed to have anever treated before and patient
also claimed to have never felt this before.
2
Patient admitted to TB treatmen in 2010 for 6 months. Denied a history of TB
medication discontinuation by patients. Positive smoking history as much as 2 packs a day
since the age of 11 years and quit as early as 2 months before hospital admission. History
of hypertension and diabetes is denied.
The History of Illness :
( ) Small pox ( ) Malaria ( ) Kidney stone(√ ) Chicken pox ( ) Disentri ( ) Burut (Hernia)( ) Difthery ( ) Hepatitis ( ) Prostat( ) Pertusis ( ) Tifus Abdominalis ( ) Melena( ) Measles ( ) Skirofula ( ) Diabetic( ) Influenza ( ) Sifilis ( ) Alergyc( ) Tonsilitis ( ) Gonore ( ) T u m o r( ) Kholera ( ) Hipertensi ( ) Vaskular Disease( ) Demam Rematik Akut ( ) Ulkus Ventrikuli( ) Pneumonia ( ) Ulkus Duodeni( ) Pleuritis ( ) Gastritis(√) Tuberkulosis ( ) Stone Gall others : ( ) Operation
( ) Accident
History of Family :
ConnectionAge(th)
Sex Healthy Causa of Death
Grandfather 75 Male DeathGrandmother 60 Female DeathFather 70 Male DeathMother 63 Female Death DMBrother-sister 33 Male HealthyChildren 8 Male Healthy
An any relation who suffer :Illness Yes No Connection
Alergyc √Asthma √Tuberkulosa √Artritis √Rematisme √Hipertensi √Cor √Kidney √Gaster √Diabetes √ Mother
3
ANAMNESIS SISTEMNote Complain Positif beside the title
Skin( ) Boil ( ) Hair (√) Night swet( ) Nail ( ) Yellow / Ikterus ( ) Sianotic
( ) Others
Head( ) Trauma ( ) Headache( ) Sinkop ( ) Pain of the sinus
Eye( ) Pain ( ) Inflammation of night sweat( ) Secret ( ) Eye disorder( ) yellow / Ikterus ( ) Sharpness to see
Ear( ) Pain ( ) Tinitus( ) Secret ( ) Ear disorder
( ) Deaf
Nose( ) Trauma ( ) Clogging( ) Pain ( ) Nose disorder( ) Sekret ( ) Have a cold( ) Epistaksis
Mouth( ) Lip ( ) Tongue ( ) Gums ( ) Mouth disorder( ) Membrane ( ) Stomatitis
Throat( ) Throats pain ( ) Voice (change)
Neck( ) Protruding ( ) Necks pain
Cor / Lung(√) Chest pain (Left) (√) Dyspneu( ) Pulse ( ) Hemoptoe( ) Ortopnoe (√) Cough
4
Abdomen (Gaster / intestine)( ) Puffing ( ) Acites( ) Nausea ( ) Hemoroid( ) Emesis ( ) Diarrhea( ) Hematemesis ( ) Melena( ) Disfagi ( ) Pale colour of feses ( ) Kholik ( ) Black colour of feses
( ) Nodul
Urogenital( ) Disuria ( ) Pyuria( ) Stranguri ( ) Kolik( √ ) Poliuria ( ) Oliguria(√ ) Polakisuria ( ) Anuria( ) Hematuria ( ) Urine retention( ) Kidney stone ( ) Drip urine( ) Wet the bed ( ) Prostat
Katamenis( ) Leukore ( ) Bleeding( ) Others ( )
Haid( ) Last menarche ( ) Quantity and
duration( ) Menarche
( ) frequently / no ( ) Pain ( ) Klimakterium symptom( ) Menarche disorder ( ) Post menopause
Muscle and neuro( ) Anestesi ( ) Bite less( ) Parestesi ( ) Ataksia( ) Weak muscle ( ) Hipo/hiper-estesi( ) Convultion ( ) Syncope( ) Afasia ( ) Tick( ) Amnesis ( ) Vertigo( ) Others ( ) Disartri
Ekstremitas( ) Edema ( ) Deformitas( ) Hinge pain ( ) Sianotic
5
WeightAverage weight (kg) : 75 kgHeight (cm) : 165 cm Present weight (kg) : 60 kg
(if the patient doesn’t know certainly)Steady ( )Down ( √ )Up ( )
6
THE HISTORY OF LIFE
Birth place : ( ) in home ( √) matrinity ( ) Matrinity hospital Helped by : ( ) Doctor ( √) nurse ( )Traditional matrinity
( ) Others
Imunitation History ( ) Hepatitis ( ) BCG ( ) Campak ( ) DPT ( ) Polio ( ) Tetanus
Food HistoryFrekuensi/day : 3x/dayAmount /day : 2 plate/eat (health), ½ plate/eat (illness)Variation /day : Rice, vegetables, egg, fishAppetite : Enough
Educational( ) SD ( ) SLTP ( √ ) SLTA ( ) SMK ( ) Academy
( ) Course ( ) UnschoolProblemFinancial : LowWorks : FarmerFamily : Good relationOthers : -
Body Check UpGeneral Check upHeight : 165cmWeight : 60 kgBlood Pressure : 120/80 mmhgPulse : 68 x/minute, regular, volume normalTemp : 36,5 oCBreath (frequence&type) : 23 x / minute Nutrition condition : EnoughConsciousness : Compos mentisCianotic : -General edema : -Habity : PiknikusThe way of walk : NormalMobility (active/pasive) : Active
7
The age prediction based on check up : 35
Mentality AspectsBehavior : Normal Nature of feeling : NormalThe thinking process : Normal
SkinColor : BrownEfloresensi : -Keloid : -Pigmentasi : -Hair Growth : NormalArteries : feelTouch temperature : AfebrisHumid/dry : HumidSweat : Night sweat Turgor : NormalIcterus : AnictericFat layers : -Edema : -Others : -
Lymphatic GlandSubmandibula : Untouched enlargementNeck : Untouched enlargementSupraklavikula : Untouched enlargementArmpit : Untouched enlargement
HeadFace expression : NormalFace symmetric : SymmetricHair : Black and uprootedTemporal artery : Normal
EyeExopthalmus : -Enopthalmus : -Palpebra : edeme -Lens : ClearConjungtiva : AnanemisVisus : 6/6Sklera : AnictericEye movement : Good in every side
8
Vision scope : NormalEye ball pressure : Normal Perpalpation Deviatio konjungae : -Nystagmus : -
EarDeaf : negative / negativeMembrane tymphani : intac / intacForamen : wide / wideObstruction : -Serumen : -Bleeding : -Liquid : -
Mouthlips : cyanosis -Tonsil : T1 / T1Palatal : NormalHalibsts : NoTeeth : CariesTrismus : -Farings : UnhiperemisLiquid layer : Unhiperemis, cyanosis -Tongue : Not dirty
NeckJVP : NormalTiroid gland : Untouched enlargementLimfe gland : Untouched enlargement
ChestShape : SimetricArtery : NormalBreast : Normal, man
Lung
AnteriorInspeksi Left : Asimetric, massa -, retraction -
Right : Asimetric massa -, retraction -Palpasi Left : tactil fremitus & vocal fremitus normal
Right : tactil fremitus & vocal fremitus decreasePerkusi Left : Sonor
Right : Dim
9
Auskultasi Left : Vesiculer , ronchi -, wheezing -Right : Vesiculer ↓, ronchi -, wheezing -
PosteriorInspeksi Left : Asimetric, massa -, retraction -
Right : Asimetric massa -, retraction -Palpasi Left : tactil fremitus & vocal fremitus normal
Right : tactil fremitus & vocal fremitus decreasePerkusi Left : Sonor
Right : DimAuskultasi Left : Vesiculer , ronchi -, wheezing -
Right : Vesiculer ↓, ronchi -, wheezing -
CorInspection : IC unseenPalpation : IC feel in linea midclavicula sinistra ICS VPercutionRight boundary : ICS V linea parasternalis dextraThe left boundary : ICS V linea midclavicula sinsitraUpper limit : ICS III linea parasternalis sinsitraAuskultation : heart voice I and II normal, murmur (-), gallop (-)
ArteryArtery temporalis : No distinctArtery karotis : No distinctArtery brakhialis : No distinctArtery radialis : No distinctArtery femoralis : No distinctArtery poplitea : No distinctArtery tibilias posterior : No distinct
StomachInspection : normal in 4 regionPalpation
Stomach wall : pressure pain (-)Heart : not feelLimfe : not feelKidney : ballotemen (-)
Percution : Timpani, shifting dullness (-)Auscultation : intestine sounds (+), normalRefleks stomach wall : normal
Genital (based on indication)
10
Female : no indicationOUE : no indicationFlour albus : no indication
Movement jointArm Right LeftMuscle normal normalTonus normotonus normotonusMassa Eutrofi eutrofiJoint normal normalMovement Active ActiveStrength 5 5Others
Heel and legWond/injury : not foundVarices : (-)Muscle (tonus & mass) : normotonus & eutrofiJoint : normalMovement : ActiveStrength/power : 5Edema : (-)Others : (-)
ReflexsRight Left
Tendon reflex normal normalBisep normal normalTrisep normal normalPatela normal normalAchiles normal normalCremaster not done not doneSkin reflex normal normalPatologic reflex not found not found
LABORATORY (9 April 2012)BloodHb : 13,1 gr/dl (13,5 – 18,0 gr/dl)
ESR : 0 (0 – 20 mm/hour)Leukosit : 5000/µl (4.500 – 10.700/ µl)
Variety countBasofil : 0 % (0 – 1 %)
11
Eusinofil : 0 % (1 – 3 %)
Batang : 0 % (2 – 6 %)
Segmen : 73% (50 – 70 %)
Limfosit : 21% (20 – 40 %)Monosit : 6 % (2 – 8 %)
Chemical BloodSGOT : 34 U/L (6 – 30 U/L)
SGPT : 42 U/L (6 – 45 U/L)Ureum : 9 mg/dL (10 – 40 mg/dL)Creatinine : 0,7 mg/dL (0,7 – 1,3 mg/dL)Blood Glucosa During : 372 mg/dL (70 – 200 mg/dL)Nacture Glucosa : 299 mg/dL ( < 120 mg/dL)Post Prandial Glucosa : 409 mg/dL (< 140 mg/dL)
BTA Examination : Negative Fluid WSD : types of discharge are greenish yellow pus from the pleural
cavity as much as 1000 cc, undulations +, bubbles + Culture and Resistance : Sterile
Urine : no examinationFaeces : no examination
RADIOLOGY (10 April 2012)
12
Lung: Right pleural effusion Fibrotic in the left lung, superior lobe
Cor: Difficult to assess
RADIOLOGY (14 April 2012)
Lung: Broncovaskular spots on the lower right lungMinimal right pleural effusionRadiolucent in the right inferior pulmonaryFibrotic lug superior lobe of the left
Cor: Difficult to assess
RESUMEPatients come to hospital with complaints of dyspneu. The complain held since 2
months ago and felt become heavy since one week before entering hospital. He also
complained chest pain, febris, purulent cough and night sweat. Cough is more severe if the
13
patient is seated. The patient claimed to have anever treated before and patient also
claimed to have never felt this before.
Patient admitted to TB treatment in 2010 for 6 months. Denied a history of TB
medication discontinuation by patients. Positive smoking history as much as 2 packs a day
since the age of 11 years and quit as early as 2 months before hospital admission.
Height : 165 cm
Weight : 60 kg
Blood Pressure : 120/80 mmhg
Pulse : 68 x/minute, regular, volume normal
Touch temperature : 36,5ºC, Afebris
Lung
AnteriorInspeksi Left : Asimetric, massa -, retraction -
Right : Asimetric massa -, retraction -Palpasi Left : tactil fremitus & vocal fremitus normal
Right : tactil fremitus & vocal fremitus decreasePerkusi Left : Sonor
Right : DimAuskultasi Left : Vesiculer , ronchi -, wheezing -
Right : Vesiculer ↓, ronchi -, wheezing -
PosteriorInspeksi Left : Asimetric, massa -, retraction -
Right : Asimetric massa -, retraction -Palpasi Left : tactil fremitus & vocal fremitus normal
Right : tactil fremitus & vocal fremitus decreasePerkusi Left : Sonor
Right : DimAuskultasi Left : Vesiculer , ronchi -, wheezing -
Right : Vesiculer ↓, ronchi -, wheezing -
CorInspection : IC unseenPalpation : IC feel in linea midclavicula sinistra ICS V
14
PercutionRight boundary : ICS V linea parasternalis dextraThe left boundary : ICS V linea midclavicula sinsitraUpper limit : ICS III linea parasternalis sinsitraAuskultation : heart voice I and II normal, murmur (-), gallop (-)
LABORATORY (9 April 2012)BloodHb : 13,1 gr/dl (13,5 – 18,0 gr/dl)
ESR : 0 (0 – 20 mm/hour)Leukosit : 5000/µl (4.500 – 10.700/ µl)
Variety countBasofil : 0 % (0 – 1 %)
Eusinofil : 0 % (1 – 3 %)
Batang : 0 % (2 – 6 %)
Segmen : 73% (50 – 70 %)
Limfosit : 21% (20 – 40 %)Monosit : 6 % (2 – 8 %)
Chemical BloodSGOT : 34 U/L (6 – 30 U/L)
SGPT : 42 U/L (6 – 45 U/L)Ureum : 9 mg/dL (10 – 40 mg/dL)Creatinine : 0,7 mg/dL (0,7 – 1,3 mg/dL)Blood Glucosa During : 372 mg/dL (70 – 200 mg/dL)Necture Glucosa : 299 mg/dL ( < 120 mg/dL)Post Prandial Glucosa : 409 mg/dL (< 140 mg/dL)
BTA Examination : Negative Fluid WSD : types of discharge are greenish yellow pus from the pleural
cavity as much as 1000 cc, undulations +, bubbles + Culture and Resistance : Sterile
Working diagnose and basic diagnose 1. Working diagnose
Right Lung Empiema e.c Lung Tuberculosis, old case + DM type II
2. Basic Diagnose Anamnesis :Dyspneu, Sputum cough, Chest pain, Hard breathing, Night sweat,and Weakness
15
Has a history of TB treatmentPhysical ExaminationLung:
I :Asimetric, hemithorax dextra laggingP:Tactile and vocal fremitus lagging P: Dim/ ResonantA:Right lung Vesiculer ↓, Ronkhi -, Wheezing -
Support checkup : Chest X-Ray : Lung: (10 April 2012)
Right pleural effusion Fibrotic in the left lung, superior lobe(14 April 2012)Broncovaskular spots on the lower right lungMinimal right pleural effusionRadiolucent in the right inferior pulmonaryFibrotic lug superior lobe of the left
Blood Blood Glucosa During : 372 mg/dLNacture Glucosa : 299 mg/dLPost Prandial Glucosa : 409 mg/dL
Differencial diagnose 1. Differencial diagnose
Right Lung Empiema ec Non Tuberculosis + DM type II2. Differencial basic diagnose
Culture and Resistance of the Pus is SterileBTA Sputum Negative
Plan treatment1. General Treatment
IVFD RL gtt XX/ minMethyl prednisolone 4 mg, 3x1Metformin 500 mg 3 x 1 tabB1, B6, B12 3 x 1 tabRanitidine injection 0f 1 ampoule/ 12 hoursSpooling with 0,9 % NaCl 100 cc per dayObserve the development of WSD if the undulations and Bubble negativeChest X-Ray if the lug re-expands, then off WSDInjection ketorolac drip 1 ampoule/ 12 hours1700 kKal per day diet
2. Prevention - Do not smoke and avoid pollution and cigarette smoke- Diligent exercise and of drinking water
16
- Avoid keeping your diet and foods containing sugar- Keep somewhat wounded- Diet to lose weight
PrognoseQuo ad vitam : Dubia ad bonamQuo ad functionam : Dubia ad bonamQuo ad sanationam : Dubia ad bonam
17
Follow up
Date 9/ 04 / 2012 10 / 04 / 2012 11 / 04 / 2012
Clinical symptoms :
- Right chest has liquid
- Painful breathing
- Blown
- Cough
- Back flushing such as
burs
- Pain at the site of
puncture WSD
(+)
(+)
(+)
(+)
(+)
(-)
(+)
(+)
(+)
(+)
(+)
(-)
(+)
(-)
(+)
(+)
( - )
(+)
General State Of Looks sick is
Awareness Compos mentis
Vital sign
- BP
- Temperature
- RR
- HR
120/80 mm
Hg
36,30 C
20 x / menit
110/70 mmHg
36,70 C
22 x / menit
70 x / menit
120/70 mm Hg
36,5 C
22x / menit
70 x / menit
18
68 x / menit
Physical Examination
- Inspection
- Palpation
- Percution
- Auscultation
Asimetric, right chest decrease, massa -, retraction -
Right chest tactil fremitus & vocal fremitus decrease
Dim / Sonor
Vesiculer +/+, ronchi -/-, wheezing-/ -
Asimetric, right chest decrease, massa -, retraction -
Right chest tactil fremitus & vocal fremitus decrease
Dim / Sonor
Vesiculer +/+, ronchi -/-, wheezing-/ -
Asimetric, right chest decrease, massa -, retraction -
Right chest tactil fremitus & vocal fremitus decrease,Crepitation on the neck and axilla
Dim / Sonor
Vesiculer +/+, ronchi -/-, wheezing-/ -
WSDyellow-green pus liqu
id with a amount of
500cc,
undulations and positi
ve bubble
yellow-green pus liq
uid with a amount of
200cc/day,
undulations and posi
tive bubble
RontgenLung: Right pleural effusion, Fibrotic in the left lung, superior lobeCor:Difficult to assess
LaboratoriumBlood glucose during 372 mg/dL
- -
19
TherapyIVFD RL gtt XX/ minInj. Ceftriaxone 1 g /12 hourMethyl prednisolone 4 mg, 3x1Metformin 500 mg, 3 x 1 tabB1, B6, B12 3 x 1 tabRanitidine injection 0f 1 ampoule/ 12 hours1700 kKal per day diet
IVFD RL gtt XX/ minInj. Ceftriaxone 1 g / 12 hourMethyl prednisolone 4 mg, 3x1Metformin 500 mg, 3 x 1 tabB1, B6, B12 3 x 1 tabRanitidine injection 0f 1 ampoule/ 12 hoursCiprofloxacin infusion 200mg, 2x1Metronidazol infusion 500 mg, 3x1Spooling with 0,9 % NaCl 100 cc per dayObserve the development of WSD if the undulations and Bubble negativeChest X-Ray if the lug re-expands, then off WSDInjection ketorolac drip 1 ampoule/ 12 hours1700 kKal per day diet
IVFD RL gtt XX/ minInj. Ceftriaxone 1 g / 12 hourMethyl prednisolone 4 mg, 3x1Metformin 500 mg, 3 x 1 tabB1, B6, B12 3 x 1 tabRanitidine injection 0f 1 ampoule/ 12 hoursCiprofloxacin infusion 200mg, 2x1Metronidazol infusion 500 mg, 3x1Spooling with 0,9 % NaCl 100 cc per dayObserve the development of WSD if the undulations and Bubble negativeChest X-Ray if the lug re-expands, then off WSDInjection ketorolac drip 1 ampoule/ 12 hours1700 kKal per day diet
20
Date 12/ 04 / 2012 13 / 04 / 2012 14 / 04 / 2012
Clinical symptoms :
- Right chest has liquid
- Painful breathing
- Blown
- Cough
- Back flushing such as
burs
- Pain at the site of
puncture WSD
(-)
(+)
(+)
(-)
(-)
(+)
(-)
(+)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
General State Of Looks sick is
Awareness Compos mentis
Vital sign
- BP
- Temperature
- RR
- HR
120/80 mm Hg
360 C
24 x / menit
68 x / menit
110/70 mmHg
36,30 C
22 x / menit
72 x / menit
110/80 mm Hg
36,6 C
22x / menit
70 x / menit
Physical Examination
- Inspection Asimetric, right Asimetric, right Asimetric, right
21
- Palpation
- Percution
- Auscultation
chest decrease, massa -, retraction -
Right chest tactil fremitus & vocal fremitus decrease
Dim / Sonor
Vesiculer +/+, ronchi -/-, wheezing-/ -
chest decrease, massa -, retraction -
Right chest tactil fremitus & vocal fremitus decrease
Dim / Sonor
Vesiculer +/+, ronchi -/-, wheezing-/ -
chest decrease, massa -, retraction -
Right chest tactil fremitus & vocal fremitus decrease,Crepitation on the neck and axilla
Dim / Sonor
Vesiculer +/+, ronchi -/-, wheezing-/ -
WSDyellow-green pus li
quid with a small
of
amount, undulation
s and positive bubb
le
Undulation and
bubble negative
Repotition WSD
Rontgen- Pro Rontgen Lun
g:Broncovaskular spots on the lower right lungMinimal right pleural effusionRadiolucent in the right inferior pulmonaryFibrotic lug superior lobe of the leftCor: Difficult to
assess
TherapyIVFD RL gtt XX/ min
IVFD RL gtt XX/ min
IVFD RL gtt XX/ min
22
Methyl prednisolone 4 mg, 3x1Metformin 500 mg 3 x 1 tabB1, B6, B12 3 x 1 tabRanitidine injection 0f 1 ampoule/ 12 hoursCiprofloxacin infusion 200mg, 2x1Metronidazol infusion 500 mg, 3x1Spooling with 0,9 % NaCl 100 cc per dayObserve the development of WSD if the undulations and Bubble negativeChest X-Ray if the lug re-expands, then off WSDInjection ketorolac drip 1 ampoule/ 12 hours1700 kKal per day diet
Methyl prednisolone 4 mg, 3x1Metformin 500 mg 3 x 1 tabB1, B6, B12 3 x 1 tabRanitidine injection 0f 1 ampoule/ 12 hoursSpooling with 0,9 % NaCl 100 cc per dayObserve the development of WSD if the undulations and Bubble negativeChest X-Ray if the lug re-expands, then off WSD1700 kKal per day diet
Methyl prednisolone 4 mg, 3x1Metformin 500 mg 3 x 1 tabB1, B6, B12 3 x 1 tabRanitidine injection 0f 1 ampoule/ 12 hoursSpooling with 0,9 % NaCl 100 cc per dayObserve the development of WSD if the undulations and Bubble negativeChest X-Ray if the lug re-expands, then off WSD1700 kKal per day diet
23
TUBERCULOSIS
TB is a infection disease that caused of mycobacterium tuberculosis. The spots of
TB infection germ are respiratory tracts, absorption tracts and opened injury in skin. Most
of TB infection occur pass through air , by means of droplet inhalation that consist of
basil which come from person who infected. The spreading capacity from a sufferer is
depended on the number of germ that issued from the lung.someone might be infected by
TB from the droplet concentration in the air, and how long they breath that air.
TB is a disease that controlled by imunity response insequenced cell. Efector cells
are macrofag and limfosit ( usually T cell ). They are imunoresponsive cells. This type
usually local, involving macrofag which actived in infection spot by limfosit and it’s
limfokin. The response is called as hypersensitivity cellular reaction ( slow reaction )
CLASSIFICATION OF TBC BASE ON THE HISTORY
1. Primary TBC
it’s happen when someone attack primarly by TBC germ. The infection started
when the TBC germ replicated successfully in the lung. That’s cause the inflammation.
Limfe tractus will carry TBC germ into limfe gland around lung hilus and it.s called as
primary complexs.
Time between infection happens until primary complexs form are around 4 – 6 weeks.
The infection cold be proven by by the occur of tuberculin reaction that changes from
negative into positive. The incubation period is time needed from infected till become
sick, approximated for about 6 month.
2. After Primary TBC
Usually happen after several month or year. After primary infection, for example
because of the descent body defense in consequence infected by HIV or malnutrient
status. The main characteristic for after primary TBC is the broadening lung damage in
occurring cavity or pleural effusion.
24
Primary Progressive Tuberculosis
Active tuberculosis develops in only 5% to 10% of persons exposed to M
tuberculosis. When a patient progresses to active tuberculosis, early signs and symptoms
are often nonspecific. Manifestations often include progressive fatigue, malaise, weight
loss, and a low-grade fever accompanied by chills and night sweats.22 Wasting, a classic
feature of tuberculosis, is due to the lack of appetite and the altered metabolism associated
with the inflammatory and immune responses. Wasting involves the loss of both fat and
lean tissue; the decreased muscle mass contributes to the fatigue.23 Finger clubbing, a late
sign of poor oxygenation, may occur; however, it does not indicate the extent of
disease.24 A cough eventually develops in most patients. Although the cough may initially
be nonproductive, it advances to a productive cough of purulent sputum. The sputum may
also be streaked with blood. Hemoptysis can be due to destruction of a patent vessel
located in the wall of the cavity, the rupture of a dilated vessel in a cavity, or the formation
of an aspergilloma in an old cavity. The inflamed parenchyma may cause pleuritic chest
pain. Extensive disease may lead to dyspnea or orthopnea because the increased interstitial
volume leads to a decrease in lung diffusion capacity. Although many patients with active
disease have few physical findings, rales may be detected over involved areas during
inspiration, particularly after a cough. Hematologic studies might reveal anemia, which is
the cause of the weakness and fatigue. Leukocytosis may also occur because of the large
increase in the number of leukocytes, or white blood cells, in response to the infection.7
PATOGENENCY
The risk factor are :
1. must have infection sorce
2. the number of bacillus as an infection cause must be sufficient
3. the high virulence of TBC bacillus
4. The descent of body defense make the bacillus reproduce
Clinic illustration :
1. The main symptom
Continous cough with/without sputum during 3 weeks or more
2. Additional symptom
25
- Sputum mixed with blood
- Haemoptoe
- Dyspnea and chest pain
- Weakness
- Night sweat
- Decrease weight
- Feverish fever more than 1 month
DIAGNOSIS
Lung TBC diagnosis can be stood at by BTA finding in sputum inspection microscopicly.
The inspection result tangibled positive if at least 2 from 3 SPS specimen must be positive.
If only 1 specimen which positive, so it’s needed a further check up, that is chest x-ray
photo or SPS sputum check up repeated.
a. If the x-ray result supports TBC, so the patient is diagnosed as TBC BTA sufferer
positive
b. If the x-ray result unsupports TBC, so the sputum check up repeated
If three sputum specimen are negative, give an extensive spectrum antibiotic during 1-2
weeks. If the condition still bad, do SPS sputum check up repeated.
a. If the SPS result are positive, diagnosed as infection TBC BTA infected
b. If the SPS result are still negative, do thr chest X-ray check up.
If the X-ray result supports TBC, diagnosed as negative BTA patient but
the X-ray positive
If the X-ray result not supports TBC, the patient is not TBC.
MEDICAL TREATMENT
Purpose :
1. Cure the patient
2. Prevent death
3. Prevent relapse
26
4. Decreasing the level of spreading
Category 1 (2HRZE/4H3R3) :
New patient lung TBC positive BTA
Patient lung TBC negative BTA, X-ray positive who got serious illness
Patient heavy extra lung TBC
Intensive stage consist of Isoniasid(H), Rifampicin(R), Pirazinamid(Z), dan Etambutol(E).
Those medicine are given everyday during two (2) month (2HRZE). Then continued by
next stage, that consists of Isoniasid(H), and Rifampicin(R). Given three times a week
during four month (4H3R3).
Category 2 (2HRZES/HRZE/5H3R3E3) :
Relaps patient
Failure patient
After default patient
Intensive stage are given for three month consists of HRZES during 2 month given
everyday (2HRZES), continued by HRZE during 1 month given every day (HRZE). Then
continued by next stage that consists of HRE during 5 month given 3 times a week.
Category 3 (2HRZES/4H3R3) :
New patient BTA negative and X-ray positive, light ill.
Patient extra light lung, it is TBC limfadenitis, pleuritis eksudativa unilateral, skin
TBC, bone TBC (except backbone), joint TBC and adrenal gland.
Intensive stage consist of HRZ, given everyday during 2 month(2HRZ), continued by
sequel stage that consist of HR during 4 month given 3 times a week(4H3R3). One packet
of Combipac 3rd category contents of 114 daily blister that consist of 60 blister HRZ for
the intensive stage and 54 blister HR for the sequel stage each packed in a small doss and
bounded in a big doss.
Implied OAT (HRZE)
If the end of intensive treatment of new patient BTA positive in 1st category or patient
BTA positive retreatment by category 2nd, sputum check up result still BTA positive
(positive BTA), given medical implied (HRZE) everyday during 1 month.
27
COMPLICATION OF TUBERCULOSIS
Without treatment, tuberculosis can be fatal. Untreated active disease typically affects
your lungs, but it can spread to other parts of the body through your bloodstream.
Examples include:
Bones. Spinal pain and joint destruction may result from TB that infects your bones. In
many cases, the ribs are affected.
Brain. Tuberculosis in your brain can cause meningitis, a sometimes fatal swelling of
the membranes that cover your brain and spinal cord.
Liver or kidneys. Your liver and kidneys help filter waste and impurities from your
bloodstream. These functions become impaired if the liver or kidneys are affected by
tuberculosis.
Heart. Tuberculosis can infect the tissues that surround your heart, causing
inflammation and fluid collections that may interfere with your heart's ability to pump
effectively. This condition, called cardiac tamponade, can be fatal.
PLEURAL EFFUSION IS CAUSED BY TUBERCULOSIS
DEFINITION
A pleural effusion is a collection of fluid in the space between the two linings (pleura) of
the lung.
28
Pleural effusion is excess fluid that accumulates between the two pleural layers, the fluid-
filled space that surrounds the lungs. Excessive amounts of such fluid can impair breathing
by limiting the expansion of the lungs during ventilation.
When we breathe, it is like a bellows. We inhale air into our lungs and the ribs move out
and the diaphragm moves down. For the lung to expand, its lining has to slide along with
the chest wall movement. For this to happen, both the lungs and the ribs are covered with a
slippery lining called the pleura. A small amount of fluid acts as a lubricant for these two
surfaces to slide easily against each other.
Too much fluid impairs the ability of the lung to expand and move.
Pleural fluid is secreted by the parietal layer of the pleura and reabsorbed by the visceral
layer of the pleura.
Types of fluids
Four types of fluids can accumulate in the pleural space:
Serous fluid (hydrothorax)
Blood (haemothorax)
Chyle (chylothorax)
Pus (pyothorax or empyema)
ETIOLOGI
A pleural effusion is not normal. It is not a disease but rather a complication of an
underlying illness. Extra fluid (effusion) can occur for a variety of reasons. Common
classification systems divide pleural effusions based on the chemistry composition of the
fluid and what causes the effusion to be formed. Two classifications are 1) transudate
pleural effusions; and 2) exudate pleural effusions. Sometimes the pleural effusion can
have characteristics of both a transudate and an exudate.
1. Transudate pleural effusions are formed when fluid leaks from blood vessels into the
pleural space. Chemically, transudate pleural effusions contain less protein and LDH
(lactate dehydrogenase) than exudate pleural effusions. If both the pleural fluid–to–serum
total protein ratio is less than or equal to 0.50 and the pleural fluid–to–serum LDH ratios
are less than or equal to 0.67, the fluid is usually considered to be a transudate while
exudates ratios are above 0.50 and above 0.67.
Examples of transudate pleural effusions include:
29
congestive heart failure ,
liver failure or cirrhosis,
kidney failure or nephritic syndrome, and
peritoneal dialysis .
2. Exudate pleural effusions are caused by inflammation of the pleura itself and are often
due to disease of the lung.
Examples of exudate causes include:
lung or breast cancer,
lymphoma,
pneumonia ,
tuberculosis ,
post pericardotomy syndrome,
systemic lupus erythematosus ,
uremia or kidney failure,
Meigs syndrome,
pancreatic pseudocyst ,
ascites ,
intra abdominal abscess, and
asbestosis and mesothelioma.
Most pleural effusions are caused by congestive heart failure, pneumonia, pulmonary
embolism and malignancy.
Transudate Exudate
Main causes
Increased hydrostatic
pressure,
Decreased colloid
osmotic pressure
Inflammation
Appearance Clear[5] Cloudy[5]
Specific gravity < 1.012 > 1.020
Protein content < 25 g/L > 35 g/L[6]
fluid protein
serum protein< 0.5 > 0.5[7]
Difference of > 1.2 g/dL < 1.2 g/dL[8]
30
albumin content
with blood albumin
fluid LDH
upper limit for serum< 0.6 or < ⅔ > 0.6[6] or > ⅔[7]
Cholesterol content < 45 mg/dL > 45 mg/dL[6]
See also: Rivalta test
SIGN AND SYMPTOM
Shortness of breath is the most common symptom of a pleural effusion. As the effusion
grows larger with more fluid, the harder it is for the lung to expand and the more difficult
it is for the patient to breathe.
Chest pain occurs because the pleural lining of the lung is irritated. The pain is usually
described as pleuritic, defined as a sharp pain, worsening with a deep breath. While the
pain may be localized to the chest, if the effusion causes inflammation of the diaphragm
(the muscle that divides the chest from the abdominal cavity) the pain may be referred to
the shoulder or the upper abdomen. As the pleural effusion increases in size, the pain may
increase.
Other associated symptoms are due to the underlying disease. For example, individuals
with:
congestive heart failure may complain of swelling of their feet and shortness of breath
when laying flat, (orthopnea) or wakening them in the middle of the night (paroxysmal
nocturnal dyspnea);
tuberculosis may be have night sweats, cough up blood (hemoptysis), and loose weight;
hemoptysis may have associated infection and lung cancer;
pneumonia may complain of fever, shaking chills, cough producing colored sputum
and pleuritic pain.
Many patients with pleural effusions are asymptomatic. However, when symptoms arise,
they do so because of pleural inflammation or the effusion's effects on mechanics. The
most common symptoms of pleural effusion are dyspnea, nonproductive cough, and
pleuritic chest pain.
The mechanisms by which dyspnea occurs are not well understood, but they do not appear
to correlate with blood oxygen levels or the size of the pleural effusion. Dyspnea is
probably related to increased thoracic cage size, which affects respiratory muscle function.
31
Nonproductive cough may occur secondary to lung compression and resultant bronchial
irritation.
Pleuritic chest pain is associated with inflammation of the parietal pleura. Pain is
occasionally referred to the abdomen. If the central portion of diaphragmatic pleura is
involved, patients experience pain in the lower chest and ipsilateral shoulder
simultaneously. Historical features, including underlying disease processes, drug use, and
radiation therapy, can alert you to the possibility of pleural effusion in a patient with less
common symptoms.
Several physical findings suggest the presence of pleural effusion. Tactile fremitus is lost
over the area of effusion because voice-induced vibrations are attenuated by the fluid
adjacent to aerated lung. This finding is more sensitive than the use of percussion for
detecting pleural fluid collections.
Absent or diminished breath sounds over the area of effusion are characteristic. Pleural
friction rubs are occasionally noted in the initial stages or as the effusion resolves and are
caused by roughened pleural surfaces moving across one another.
DIAGNOSTIC AND TEST
Pleural effusion is usually diagnosed on the basis of medical history and physical exam,
and confirmed by chest x-ray. Once accumulated fluid is more than 300 ml, there are
usually detectable clinical signs in the patient, such as decreased movement of the chest on
the affected side, stony dullness to percussion over the fluid, diminished breath sounds on
the affected side, decreased vocal resonance and fremitus (though this is an inconsistent
and unreliable sign), and pleural friction rub. Above the effusion, where the lung is
compressed, there may be bronchial breathing and egophony. In large effusion there may
be tracheal deviation away from the effusion. A systematic review (2009) published as
part of the Rational Clinical Examination Series in the Journal of the American Medical
Association (JAMA) showed that dullness to conventional percussion was most accurate
for diagnosing pleural effusion (summary positive likelihood ratio, 8.7; 95% confidence
interval, 2.2–33.8), while the absence of reduced tactile vocal fremitus made pleural
effusion less likely (negative likelihood ratio, 0.21; 95% confidence interval, 0.12–0.37).[2]
Pleural effusions are often discovered by doctors attempting to determine the source of a
patient's symptoms. For example, a doctor examining a patient with a stethoscope may
notice soft breathing or a dull sound when tapping the patient's chest.
32
If a doctor suspects the existence of a pleural effusion, he or she may order X-rays to
confirm the diagnosis and determine how much fluid is present in the pleural space. If
congestive heart failure has been ruled out, the doctor may then perform a procedure
called thoracentesis to extract a small sample of the pleural fluid for analysis. Also known
as pleural fluid aspiration, this relatively painless procedure is done by inserting a needle
between the ribs to access the pleural space. The fluid is then extracted and examined
under a microscope to look for cancerous cells, bacteria and a protein called mesothelin.
New research suggests that high levels of mesothelin may indicate mesothelioma.
Ultrasound and/or a thoracic CT scan (CT scan of the chest) may also be ordered to
diagnose pleural effusions.
MECHANISME PLEURAL EFFUSION IN TUBERCULOSIS
The pleural space is 10 to 20 µm in width and normally contains about 0.1 mL/kg of fluid.
A volume greater than 7 to 14 mL is abnormal. Many mechanisms can result in abnormal
amounts of pleural fluid, including:
Increased hydrostatic pressures in the microvascular circulation.
Decreased oncotic pressures in the microvascular circulation.
Decreased pleural space pressure (resulting from lung collapse).
Increased permeability of the microvascular circulation.
Obstruction of lymphatic drainage
Generally, transudative effusions are formed in response to increased hydrostatic pressure,
while exudative effusions form when pleural inflammation or disrupted lymphatic
drainage results in increased protein leak or decreased protein removal from the pleural
space. In CHF, pleural effusions are secondary to pulmonary venous hypertension.
Neoplasms can cause pleural effusions by direct involvement of the pleura, by lymphatic
obstruction, or in association with a post-obstructive pneumonia. Pleural effusions
associated with pulmonary embolism are secondary to increased capillary permeability,
pleuropulmonary hemorrhage, and increased hydrostatic pressure.
Many different things can cause pleural effusion. Heart failure or other heart and lung
problems may cause pleural effusion. Infections (in-FECK-shuns) such as pneumonia
(noo-MOH-nyah) or tuberculosis (TB) may cause pleural effusion. Inflammation of the
pleura, called pleurisy (PLOOR-i-see), may cause pleural effusion. Other causes may
include cancer, injury, or problems with other organs in your chest or abdomen (belly).
33
Pleural effusion is a secondary disease being related to tuberculosis or other lung disease
such as TB, pneumonia etc. because there is irritation on the lining of pleural cavity, thus
altering the permeability of the membrane and decreasing the oncotic pressure needed to
drain the excess fluid in the pleural space. normally there is a small amount of pleural fluid
in the pleural space that lubricates the parietal and visceral pleura during expiring and
inspiring.
Primary pulmonary tuberculosis is often asymptomatic, so that the results of diagnostic
tests are the only evidence of the disease. Although primary disease essentially exists
subclinically, some self-limiting findings might be noticed in an assessment. Associated
paratracheal lymphadenopathy may occur because the bacilli spread from the lungs
through the lymphatic system. If the primary lesion enlarges, pleural effusion is a
distinguishing finding. This effusion develops because the bacilli infiltrate the pleural
space from an adjacent area. The effusion may remain small and resolve spontaneously, or
it may become large enough to induce symptoms such as fever, pleuritic chest pain, and
dyspnea. Dyspnea is due to poor gas exchange in the areas of affected lung tissue.
Dullness to percussion and a lack of breath sounds are physical findings indicative of a
pleural effusion because excess fluid has entered the pleural space.
COMPLICATION
Complications of pleural effusions include collapse of the lung; pneumothorax, or air in
the chest cavity, which is a common side effect of the thoracentesis procedure; and
empyemas (abscesses) caused by infection of the pleural fluid, which require drainage of
the fluid.
Pleural effusion can place patients with asbestosis or mesothelioma at even more risk than
other patients — if it leads to difficulty breathing. This is because patients with these
conditions so often suffer from pleural scarring, which itself makes it extremely difficult
to breathe. Pleural effusion can exacerbate this problem, and ultimately the inability to
breathe properly can contribute significantly to the patient's downward spiral.
Risks:
A pleural effusion may cause or worsen a lung infection, such as pneumonia. The extra
fluid may get infected and form a pocket of pus, which is called empyema (em-peye-EE-
ma). You may have other problems, such as a collapsed lung. The problems you may have
depend on what is causing your pleural effusion. Talk to your caregiver about any
concerns you may have about your illness or treatment.
34
TREATMENT
In some cases, no treatment is required for pleural effusions. However, when doctors link
the fluid build-up to a patient's discomfort or pain — or to other, more serious side effects
— they often take measures to address the cause and/or effects of the effusion. As
previously mentioned, a patient suffering from asbestosis or mesothelioma may experience
more than one condition that makes it difficult to breathe. To address this, doctors do
whatever they can to treat the root causes.
For patients with pleural-effusion-related breathing problems, this may include the
following:
Thoracentesis. Further extraction of pleural fluid can alleviate pressure in the chest,
making it easier to breathe.
Once a pleural effusion is diagnosed, the cause must be determined. Pleural fluid is drawn
out of the pleural space in a process called thoracentesis. A needle is inserted through the
back of the chest wall in the sixth, seventh, or eighth intercostal space on the midaxillary
line, into the pleural space. The fluid may then be evaluated for the following:
1. Chemical composition including protein, lactate
dehydrogenase (LDH), albumin, amylase, pH, and glucose
2. Gram stain and culture to identify possible bacterial infections
3. Cell count and differential
4. Cytopathology to identify cancer cells, but may also identify some infective
organisms
5. Other tests as suggested by the clinical situation – lipids, fungal culture, viral
culture, specific immunoglobulins
Chemical pleurodesis. This procedure involves the insertion of agents such as talc or
bleomycin to eliminate the pleural space altogether, so that fluid can no longer build up.
Therapeutic aspiration may be sufficient; larger effusions may require insertion of
an intercostal drain (either pigtail or surgical). When managing these chest tubes, it is
important to make sure the chest tubes do not become occluded or clogged. A clogged
chest tube in the setting of continued production of fluid will result in residual fluid left
behind when the chest tube is removed. This fluid can lead to complications such as
hypoxia due to lung collapse from the fluid, or fibrothorax, later, when the space scars
down. Repeated effusions may require chemical
35
(talc, bleomycin, tetracycline/doxycycline), or surgical pleurodesis, in which the two
pleural surfaces are scarred to each other so that no fluid can accumulate between them.
This is a surgical procedure that involves inserting a chest tube, then either mechanically
abrading the pleura or inserting the chemicals to induce a scar. This requires the chest tube
to stay in until the fluid drainage stops. This can take days to weeks and can require
prolonged hospitalizations. If the chest tube becomes clogged, fluid will be left behind and
the pleurodesis will fail.
Pleurodesis fails in as many as 30% of cases. An alternative is to place a PleurX Pleural
Catheter or Aspira Drainage Catheter. This is a 15Fr chest tube with a one-way valve.
Each day the patient or care givers connect it to a simple vacuum tube and remove from
600 cc to 1000 cc of fluid. This can be repeated daily. When not in use, the tube is capped.
This allows patients to be outside the hospital. For patients with malignant pleural
effusions, it allows them to continue chemotherapy, if indicated. Generally the tube is in
for about 30 days and then it is removed when the space undergoes a spontaneous
pleurodesis.
Pleural decortication. Also called pleurectomy, this surgery removes the pleura; like
chemical pleurodesis, pleural decortication eliminates the pleural space, thereby
preventing pleural fluid from building up.
Mesothelioma Lawyers
For more information on mesothelioma symptoms and other issues related to asbestos
exposure, asbestosis and malignant mesothelioma, please refer to other articles on our site.
If you or a family member has been diagnosed with an asbestos-related disease, contact a
mesothelioma attorney as soon as possible.
The treatment you receive may depend on what is causing your pleural effusion and how
bad your symptoms are. You may need medicines such as antibiotics (an-ti-bi-AH-tiks) to
prevent or treat a bacterial (bak-TEE-ree-al) infection. Steroids and other kinds of
medicines may be given to decrease inflammation. You may need medicines for pain.
Diuretic (deye-yoo-RET-ik) medicine may help you lose extra fluid caused by heart
failure or other problems. You may need to have the extra pleural fluid removed by having
a thoracentesis (thohr-ah-sen-TEE-sis) or a chest tube. During a thoracentesis, a needle is
used to remove the extra pleural fluid from around a lung. This fluid may be sent to the lab
for tests. A thoracentesis may help you breathe easier, and help your caregiver find the
36
best way to treat you. A chest tube is a tube that stays in your chest for days or weeks.
This lets the extra fluid around your lung drain out over time. You may need medicines
put directly into your chest if the fluid does not drain out easily.
Some people have pleural effusions that come back over and over. For example, a tumor
(growth) may cause extra fluid to keep collecting around a lung. If your pleural effusion
keeps coming back or if it increases your risk for other problems, you may need surgery or
other treatments. Ask your caregiver for more information about other treatments that you
may need.
37
BIBLIOGRAPHY
Arun Gopi, Sethu M. Madhavan, Surendra K. Sharma and Steven A.Sahn. 2007.
Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006. American
College of Chest Physicians.
http://ccn.aacnjournals.org/content/29/2/34.full
http://www.allaboutmalignantmesothelioma.com/pleural-effusion.htm
http://www.consultantlive.com/display/article/10162/36884
http://www.medicinenet.com/pleural_effusion/page2.htm#risk
W, Aru. Sudoyo, et all. 2006. Ilmu Peyakit Dalam Ed IV Jilid I. Departemen Ilmu
Penyakit Dalam FKUI, Jakarta.
Yoga, Tjandra Aditama. 2006. TUBERKULOSIS PEDOMAN DAN PENATALAKSANAAN
DI INDONESIA. Perhimpunan Dokter Paru Indonesia, Jakarta.
38